Chemical Compound

(3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione

CAS Registry Number 820957-38-8
(3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione 结构式
Primary record

(3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione

库存
7,316 克
纯度
98.8 %
CAS
820957-38-8

化合物标识与属性

CAS
820957-38-8
PubChem CID
11340891
SMILES
CC[C@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](C2=COC(=N2)C)C(=O)N3CCOCC3)C4CC5=CC=CC=C5C4
Canonical SMILES
CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(C)n1

名称与同义词

  • Retosiban
  • retosibanum
  • Retosiban [USAN]
  • 820957-38-8
  • Retosiban [USAN:INN]
  • Retosiban (USAN)
  • GIE06H28OX
  • GSK221149A
  • UNII-GIE06H28OX
  • GSK-221149A
  • RETOSIBAN [INN]
  • GSK221149
  • RefChem:879490
  • D04QZI
  • GSK 221149A
  • CHEMBL429736
  • SCHEMBL230301
  • DTXSID00231559
  • GTPL8403
  • orb1706726
  • GSK-221149
  • SCHEMBL29376892
  • DTXCID80154050
  • CHEBI:188651
  • PLVGDGRBPMVYPB-FDUHJNRSSA-N
  • C27H34N4O5
  • ZINC6718496
  • BDBM50372608
  • EX-A12369
  • MFCD19443707
  • AKOS040742542
  • GSK-221,149-A
  • DB11818
  • CID11340891
  • CID 11340891
  • DA-67173
  • HY-14778
  • MS-29186
  • CS-0003555
  • NS00070346
  • GSK 221149; GSK 221149A
  • J3.542.064I
  • A13106
  • D08986
  • G14036
  • A857525
  • (3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl]piperazine-2,5-dione
  • Q7316883
  • (3R,6R)-6-((2S)-Butan-2-yl)-3-(2,3-dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl- 1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl)piperazine-2,5-dione
  • (3R,6R)-6-[(2S)-Butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl]piperazine-2,5-dione
  • Morpholine, 4-((2R)-((3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-((1S)-1- methylpropyl)-2,5-dioxo-1-piperazinyl)(2-methyl-4-oxazolyl)acetyl)-
  • (3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione
  • (3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl-4-oxazolyl)-2-(4-morpholinyl)-2-oxoethyl)-6-((1S)-1-methylpropyl)-2,5-piperazinedione
  • (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
  • (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2.5-piperazinedione
  • (3R,6R)-3-indan-2-yl-1-[(1R)-1-(2-methyloxazol-4-yl)-2-morpholino-2-oxo-ethyl]-6-[(1S)-1-methylpropyl]piperazine-2,5-dione
  • (3R,6R)-6-((2S)-BUTAN-2-YL)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-((1R)-1-(2-METHYL-1,3-OXAZOL-4-YL)-2-(MORPHOLIN-4-YL)-2-OXOETHYL)PIPERAZINE-2,5-DIONE
  • (3R,6R)-6-((2S)-butan-2-yl)-3-(2,3-dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl)piperazine-2,5-dione
  • 1-[(R)-1-(2-Methyloxazole-4-yl)-2-oxo-2-morpholinoethyl]-3beta-(indan-2alpha-yl)-6beta-[(S)-sec-butyl]piperazine-2,5-dione
  • 2,5-Piperazinedione, 3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-4-oxazolyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-, (3R,6R)-
  • MORPHOLINE, 4-((2R)-2-((3R,6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-6-((1S)-1-METHYLPROPYL)-2,5-DIOXO-1-PIPERAZINYL)-2-(2-METHYL-4-OXAZOLYL)ACETYL)-